Acquisitions for Lonza?

Lonza shareholders are advising ceo Stefan Borgas to look at larger acquisitions to expand in life sciences including drug ingredients and nutritional additives, rather than return cash to investors. Borgas said the company will have a "much tougher" time reaching profit targets this year because of rising raw-material costs and a sliding dollar.
Bloomberg